DLTR
40
4
XOM
51
3
WFC
80
-2
BMY
61
-3
SCHW
65
-2
CNP
50
-2
KHC
17
4
MMM
42
5
LOW
58
2
SLG
62
-4
AAPL
45
3
COF
63
-4
DTE
38
-4
PNR
74
5
RRC
60
-3
SIG
47
-2
FOX
57
-3
EMR
77
-2
GOOGL
59
-8
BA
45
-3
DLTR
40
4
XOM
51
3
WFC
80
-2
BMY
61
-3
SCHW
65
-2
CNP
50
-2
KHC
17
4
MMM
42
5
LOW
58
2
SLG
62
-4
AAPL
45
3
COF
63
-4
DTE
38
-4
PNR
74
5
RRC
60
-3
SIG
47
-2
FOX
57
-3
EMR
77
-2
GOOGL
59
-8
BA
45
-3
Financhill
Back

Direxion Daily S&P Biotech Bull 3X ETF Vs. Dyne Therapeutics Industry Stock Comparison

Sell
40

LABU
Direxion Daily S&P Biotech Bull 3X ETF

Last Price:
118.19
Seasonality Move:
21.42%
Buy
66

DYN
Dyne Therapeutics

Last Price:
30.40
Seasonality Move:
38.02%
Sell
40
Direxion Daily S&P Biotech Bull 3X ETF (LABU) is a Sell

Is Direxion Daily S&P Biotech Bull 3X ETF a Buy, Sell or Hold?

  • The current Direxion Daily S&P Biotech Bull 3X ETF [LABU] share price is $129.82. The Score for LABU is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • LABU is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
66
Dyne Therapeutics (DYN) is a Buy

Is Dyne Therapeutics a Buy, Sell or Hold?

  • The current Dyne Therapeutics [DYN] share price is $34.14. The Score for DYN is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
  • DYN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

LABU Stock Price Chart

What is Direxion Daily S&P Biotech Bull 3X ETF's stock price today?

  • The Direxion Daily S&P Biotech Bull 3X ETF share price today is $129.82
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LABU is experiencing selling pressure, which indicates risk of future bearish movement.

DYN Stock Price Chart

What is Dyne Therapeutics's stock price today?

  • The Dyne Therapeutics share price today is $34.14
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DYN is experiencing buying pressure, which is a positive indicator for future bullish movement.

LABU Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.8 Buy
Relative Strength Index (14 RSI): 49.15 Sell
Chaikin Money Flow: -991604 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (121.38 - 136.56) Buy
Bollinger Bands (100): (119.01 - 138.63) Buy

DYN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.99 Sell
Relative Strength Index (14 RSI): 60.64 Buy
Chaikin Money Flow: 1192325 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.99 - 33.51) Buy
Bollinger Bands (100): (31.49 - 42.59) Sell

LABU Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 136.97 Sell
20-day SMA: 129.44 Buy
50-day SMA: 128.87 Buy
200-day SMA: 123.53 Buy
8-day EMA: 134.91 Sell
20-day EMA: 131.61 Sell
50-day EMA: 129.41 Buy
200-day EMA: 123.53 Buy

DYN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.58 Buy
20-day SMA: 30.81 Buy
50-day SMA: 32.62 Buy
200-day SMA: 32.06 Buy
8-day EMA: 30.24 Buy
20-day EMA: 30.74 Buy
50-day EMA: 32.95 Buy
200-day EMA: 30.83 Buy

Direxion Daily S&P Biotech Bull 3X ETF Earnings Growth & LABU Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Dyne Therapeutics Earnings Growth & DYN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.54 per share, and an increase next year of $0.08 per share.

Direxion Daily S&P Biotech Bull 3X ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Dyne Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):